J&J and U.S. Government Earmark $1 Billion for Covid-19 Vaccine Trials – Barron’s

With Covid-19 cases surging to new records around the country, Johnson & Johnson and the U.S. government are expanding their effort to support the next phase of vaccine research.

J&J (JNJ) and the U.S. Department of Health and Human Services announced on Saturday that they were investing further in a vaccine development, according to a press release from the company. J&J is putting up $604 million and the Biomedical Advanced Research and Development Authority, or Barda, will add about $454 million to the companys Phase 3...

The rest is here:

J&J and U.S. Government Earmark $1 Billion for Covid-19 Vaccine Trials - Barron's

Related Posts
Tags: